Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 14, 2018

Total Value ($000): $159,449 (100.0% shares, 0.0% debt)

Holdings (31)

SHIRE PLC 13.7%
Value ($000) $21,828 Shares 146,114 Est. Cost $149.39 Unrealized
ALLERGAN PLC 10.0%
Value ($000) $15,954 Shares 94,800 Est. Cost $163.58 Unrealized
MGNX MACROGENICS INC 7.0%
Value ($000) $11,196 Shares 445,000 Est. Cost $18.67 Unrealized +30.1%
SBRA SABRA HEALTH CARE REIT INC 6.4%
Value ($000) $10,237 Shares 580,000 Est. Cost $18.43 Unrealized
ACHAOGEN INC 5.4%
Value ($000) $8,561 Shares 661,054 Est. Cost $11.04 Unrealized
TELIGENT INC NEW 5.2%
Value ($000) $8,308 Shares 2,472,561 Est. Cost $3.36 Unrealized
ALMOST FAMILY INC 4.7%
Value ($000) $7,560 Shares 135,000 Est. Cost $55.57 Unrealized
REATA PHARMACEUTICALS INC 3.8%
Value ($000) $6,107 Shares 297,750 Est. Cost $25.04 Unrealized
CIGNA CORPORATION 3.4%
Value ($000) $5,401 Shares 32,200 Est. Cost $167.73 Unrealized
SIERRA ONCOLOGY INC 3.3%
Value ($000) $5,255 Shares 2,538,525 Est. Cost $2.07 Unrealized
EIGER BIOPHARMACEUTICALS INC 3.3%
Value ($000) $5,229 Shares 530,848 Est. Cost $13.95 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 3.2%
Value ($000) $5,140 Shares 63,400 Est. Cost $85.82 Unrealized 0.0%
DXCM DEXCOM INC 3.0%
Value ($000) $4,820 Shares 65,000 Est. Cost $13.93 Unrealized +6.2%
ARENA PHARMACEUTICALS INC 3.0%
Value ($000) $4,756 Shares 120,400 Est. Cost $39.50 Unrealized
CIDARA THERAPEUTICS INC 3.0%
Value ($000) $4,746 Shares 1,186,355 Est. Cost $6.80 Unrealized
PIERIS PHARMACEUTICALS INC 2.4%
Value ($000) $3,845 Shares 563,763 Est. Cost $6.82 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 2.2%
Value ($000) $3,546 Shares 209,842 Est. Cost $8.03 Unrealized +88.6%
INOGEN INC 2.1%
Value ($000) $3,292 Shares 26,800 Est. Cost Unrealized
QUOTIENT LTD 2.0%
Value ($000) $3,213 Shares 682,180 Est. Cost $4.95 Unrealized
AVEO PHARMACEUTICALS INC 1.9%
Value ($000) $3,026 Shares 1,043,550 Est. Cost $2.79 Unrealized
CLOVIS ONCOLOGY INC 1.7%
Value ($000) $2,640 Shares 50,000 Est. Cost Unrealized
CIVITAS SOLUTIONS INC 1.6%
Value ($000) $2,532 Shares 164,396 Est. Cost $15.40 Unrealized
CNC CENTENE CORP DEL 1.6%
Value ($000) $2,498 Shares 23,375 Est. Cost $48.44 Unrealized +7.6%
CLOVIS ONCOLOGY INC 1.5%
Value ($000) $2,429 Shares 46,001 Est. Cost $66.02 Unrealized
PARATEK PHARMACEUTICALS INC 1.2%
Value ($000) $1,933 Shares 148,682 Est. Cost $17.90 Unrealized
KINDRED HEALTHCARE INC 0.9%
Value ($000) $1,485 Shares 162,326 Est. Cost $9.15 Unrealized
NABRIVA THERAPEUTICS PLC 0.8%
Value ($000) $1,221 Shares 242,689 Est. Cost $5.98 Unrealized
NOVELION THERAPEUTICS INC 0.5%
Value ($000) $816 Shares 233,003 Est. Cost $3.12 Unrealized
QURE UNIQURE NV 0.5%
Value ($000) $801 Shares 34,100 Est. Cost $15.23 Unrealized +43.2%
BELLICUM PHARMACEUTICALS INC 0.4%
Value ($000) $696 Shares 106,050 Est. Cost $8.41 Unrealized
AMPIO PHARMACEUTICALS INC 0.2%
Value ($000) $378 Shares 111,150 Est. Cost $3.40 Unrealized